Haematologica, Vol 92, Issue 9, 1254-1257 doi:10.3324/haematol.11279
Copyright © 2007 by Ferrata Storti Foundation
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Robin, M.
Right arrow Articles by Socié, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Robin, M.
Right arrow Articles by Socié, G.

Stem Cell Transplantation

Disseminated adenovirus infections after allogeneic hematopoietic stem cell transplantation: incidence, risk factors and outcome

Marie Robin, Stéphanie Marque-Juillet, Catherine Scieux, Régis Peffault de Latour, Christèle Ferry, Vanderson Rocha, Jean-Michel Molina, Anne Bergeron, Agnès Devergie, Eliane Gluckman, Patricia Ribaud, Gérard Socié

From Service d’hématologie – Greffe (MR, PdL, CF, VR, AD, EG, PR, GS); Laboratoire de virologie (SMJ, CS); Service de maladies infectieuses (JMM); Service de pneumologie (AB); INSERM U728 (GS), Paris, France

Correspondence: Prof. Gérard Socié, Hôpital Saint Louis, Service d’Hématologie, Greffe, 1 avenue Claude Vellefaux, 75475 Paris Cedex 10, France. E-mail: gerard.socie{at}paris7.jussieu.fr

We analyzed the factors and outcome of patients with disseminated adenovirus infection (dAdV) after allogeneic hematopoeitic stem cell transplantation (HSCT). Thirty patients with dAdV were identified among 620 allogeneic HSCT recipients. Primary diseases were leukemia (n=17), Fanconi anemia (n=12) or others (n=1). Source of stem cells was unrelated in 28 and related in 2 patients. The graft consisted of peripheral blood (n=3), bone marrow (n=12) and unrelated cord-blood (UCB, n=15). Risk factors for dAdV in unrelated HSCT recipients were previous Fanconi disease (p=0.03) and GVHD (p=0.02) in children, and cord blood source of stem cells (p=0.029) and GVHD (0.024) in adults.

Key words: adenovirus infection, allogeneic hemetopoietic stem cell transplantation, risk factors.




This article has been cited by other articles:


Home page
 BloodHome page
R. W. Childs and C. S. Zerbe
Expanding multiviral reactive T cells from cord blood
Blood, August 27, 2009; 114(9): 1725 - 1726.
[Abstract] [Full Text] [PDF]